Lynwood Capital Management Inc. - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 28 filers reported holding BRIACELL THERAPEUTICS CORP in Q2 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
Lynwood Capital Management Inc. ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q3 2023$9,890,312
-2.7%
1,582,450
-0.1%
26.01%
+102.0%
Q2 2023$10,168,497
-10.8%
1,583,878
+3.5%
12.88%
+25.2%
Q1 2023$11,398,500
+170357.6%
1,530,0000.0%10.29%
+27.9%
Q4 2022$6,687
-99.9%
1,530,000
+27.7%
8.04%
+9.4%
Q3 2022$6,733,000
+89.7%
1,198,000
+94.8%
7.35%
+85.5%
Q2 2022$3,549,000
-53.3%
615,000
-18.0%
3.96%
-51.4%
Q1 2022$7,605,000
+17.0%
750,000
-4.5%
8.16%
+31.2%
Q4 2021$6,500,000785,0006.22%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Redmond Asset Management, LLC 131,731$508,0000.16%
SABBY MANAGEMENT, LLC 160,182$618,0000.12%
ZEKE CAPITAL ADVISORS, LLC 45,000$174,0000.01%
Freedom Investment Management, Inc. 16,339$63,0000.01%
Virtu Financial LLC 15,121$58,0000.00%
TORONTO DOMINION BANK 12$00.00%
ROYAL BANK OF CANADA 17$00.00%
UBS Group AG 632$2,0000.00%
OSAIC HOLDINGS, INC. 6,012$23,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BRIACELL THERAPEUTICS CORP shareholders